Exelixis's Promising Pipeline of Drugs
Exelixis's Promising Pipeline Of Drugs
Filed under: drug treatment news 2011
The only other drug approved in 2011 for the same illness, is Caprelsa from AstraZeneca (AZN). Caprelsa sales for the first nine months of 2012 were only $ 19 million, according to Stifel Nicolaus analyst Joel Sendek. Sendek predicts that Exelixis' drug …
Read more on Seeking Alpha
TB claims 2011 CBSE class XII topper
Filed under: drug treatment news 2011
MUMBAI: The city lost one of its bright young minds on Monday when Shreeram Radhakrishnan, who topped the CBSE's class XII examinations (science stream) in 2011 in the state, died of multi-drug resistant TB (MDR-TB ) after being in an unconscious state …
Read more on Times of India
Drag-and-Drop DNA: Novel technique aiding development of new cancer drugs
Filed under: drug treatment news 2011
In vivo experiments, funded by the NSF SBIR award, validated the approach, and Parabon filed a provisional patent for its methods and compounds on May 4, 2011. The final application was published in … Working together as part of a larger molecule …
Read more on Phys.Org
Exelixis's Thyroid Cancer Treatment Gains US Approval
Filed under: drug treatment news 2011
The treatment is the FDA's 31st new drug approval this year, surpassing a seven-year high of 30 approvals in 2011. This is the second drug in two years the agency has approved to treat medullary thyroid cancer, said Richard Pazdur, director of the FDA …
Read more on Businessweek